Sudhakar Varshney compensation by year
AVANOS MEDICAL Summary Compensation Table · the one fiscal year held| Component | FY2023 |
|---|---|
| Salary | $446,000 |
| Bonus | $300,000 |
| Stock awards | $720,112 |
| Option awards | $0 |
| Non-equity incentive | $226,657 |
| Pension and deferred compensation | $0 |
| All other | $45,687 |
| Total | $1,738,456 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AVANOS MEDICAL, INC. DEF 14A filed March 15, 2024, accession 0001104659-24-034942, and prior-year filings.
How this page was built: the AVANOS MEDICAL, INC. filed document, accession 0001104659-24-034942. Every figure is read from that document and cited to the page and table it appears in. Filed March 15, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 19,128 | $429,041 | — |
| PSU | 12,463 | $279,545 | — |
| RSU | 12,463 | $279,545 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in AVANOS MEDICAL, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments AVANOS MEDICAL discloses, by trigger · FY2023| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $1,338,000 | — | $18,975 | $1,356,975 |
| Change in control and involuntary termination | $1,338,000 | $988,131 | $44,909 | $2,460,154 |
| Disability | $226,657 | $312,800 | $0 | $539,457 |
| Death | $1,118,657 | $312,800 | $0 | $1,431,457 |
Per the Potential Payments Upon Termination or Change in Control table in AVANOS MEDICAL, INC.'s FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.
AVANOS MEDICAL’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Joseph Woody | Chief Executive Officer | $7,214,563 |
| Michael Greiner | Senior Vice President, Chief Financial Officer and Chief Transformation Officer | $2,986,702 |
| Kerr Holbrook | Senior Vice President and Chief Commercial Officer | $2,147,797 |
| Mojirade James | Senior Vice President, General Counsel and Secretary | $1,903,852 |
| Sudhakar Varshney · this page | Senior Vice President, Global Supply Chain and Procurement | $1,738,456 |
| William Haydon | Senior Vice President and General Manager, Pain Franchise | $1,436,556 |
| Scott Galovan | Chief Financial Officer | $881,210 |
| Jason Pickett | Interim Chief Financial Officer | $630,280 |
| Warren Machan | Former Interim Chief Financial Officer | $390,817 |
The full AVANOS MEDICAL compensation record
free company briefThis page is one person within AVANOS MEDICAL's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the AVANOS MEDICAL proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AVANOS MEDICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.